Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Clinical trial NCT00538473 · COMPLETED
Trial details
- NCT number
- NCT00538473
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-23
- Primary completion
- 2007-12-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.